Malignant melanoma of eye (disorder)
SELPAC: A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or uninterrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.
Year Started: 2015
Clinical Trial Samples from SELPAC clinical trial: samples include plasma and tissue.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Male
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 100% |